DENTSPLY SIRONA Valuation Overview

XRAY -- USA Stock  

USD 44.72  0.41  0.91%

DENTSPLY SIRONA shows prevailing Real Value of $56.60875 per share. The current price of the firm is $44.72. At this time the firm appears to be under valued. Macroaxis computes value of DENTSPLY SIRONA from analyzing the firm fundamentals such as Operating Margin of 20.79%, Profit Margin of (38.81)% and Current Valuation of 12.64B as well as examining its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since in the future assets prices and their ongoing real values will submerge.

Valuation Drivers Correlation

Selected DENTSPLY SIRONA Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Invested Capital    
 Time Horizon     30 Days    Login   to change
DENTSPLY SIRONA is rated below average in price to earning category among related companies. It is rated below average in price to sales category among related companies .

Current Market Valuation

DENTSPLY SIRONA Valuation Boundaries
Under Valued
June 21, 2018
Market Value
Real Value
Target Odds
DENTSPLY SIRONA is not too risky asset. Calculation of real value of DENTSPLY SIRONA is based on 1 month time horizon. Increasing DENTSPLY SIRONA time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Tax Efficiency

DENTSPLY SIRONA Tax Efficiency History

Tax Efficiency

Market Capitalization

DENTSPLY SIRONA Market Capitalization Analysis
DENTSPLY SIRONA is rated below average in market capitalization category among related companies. Market capitalization of Medical Equipment industry is at this time estimated at about 214.34 Billion. DENTSPLY SIRONA holds roughly 10.24 Billion in market capitalization claiming about 5% of all equities under Medical Equipment industry.
Capitalization  Workforce  Total debt  Valuation  Revenue

Valuation Indicators

DENTSPLY SIRONA Valuation Fundamental Ratios
See also Your Current Watchlist. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.